Steven Murphy Highlights New Research Linking POTS Platelets to Storage Pool Deficiency
Steven Murphy, Medical Director, Concierge Medical Associates, shared a post on LinkedIn:
“Are POTS patients’ platelets different? Should we be avoiding PRP in them?
What about in patients with Long COVID and POTS?
An interesting research article was published
“Postural orthostatic tachycardia syndrome in post-COVID-19 long-hauler patients is associated with platelet storage pool deficiency”
Title: Postural orthostatic tachycardia syndrome in post-COVID-19 long-hauler patients is associated with platelet storage pool deficiency
Authors: William T. Gunning III, Saira Khan, John W. Spatafore, Beverly L. Karabin, Blair P. Grubb
Read more here.
Both POTS groups have δ-SPD, AKA dense (delta) granule storage pool deficiency. There also is a genetic version, but this was not assessed in this study.
PRP has 7 fundamental proteins: platelet derived growth factors (PDGF), transforming growth factor–β (TGF-β), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and adhesive proteins – fibrin, fibronectin, and vitronectin…. we think these are the main factors in the success of it.
But my main man Peter A. Everts, PhD, FRSM reviews even more factors.
Title: Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
Authors: Peter Everts, Kentaro Onishi, Prathap Jayaram, José Fábio Lana, Kenneth Mautner
Read more here
Dense granules effect platelet activation and Alpha granules contain good stuff. I also add, mitochondria can travel between cells and I posit also help healing in the injured tissue.
But the problem I have is this: Both scenarios above point to platelets that are not “normal”: in long COVID POTS they may be chronically activated/exhausted, and in regular POTS they have intrinsic granule deficits. These features overlap with the concept of platelet senescence or aging. As platelets age (or undergo repeated activation), they lose granule content and responsiveness while gaining pro-inflammatory behavior.
A 2025 review on platelet aging notes that senescent platelets display reduced granule content, impaired responsiveness, and heightened pro-inflammatory factor release, all of which can compromise tissue repair processes.
So I ask all OBX brothers and sisters, what do you do with your POTS or Long COVID POTS patients?
I will be investigating this on my substack next week”
Stay updated with Hemostasis Today.
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders